ID   4D20.8
AC   CVCL_RU14
SY   4-D20-8; PureStem 4D20.8, NCr-fac progenitor; ACTC84
DR   Millipore; SCC120
DR   Millipore; SCR220
DR   Wikidata; Q54603382
RX   Patent=US8685386;
RX   PubMed=18462054;
RX   PubMed=22519755;
WW   http://www.esibio.com/purestemr-4d20-8-ncr-fac-progenitor/
CC   Group: Patented cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10231.
CC   Characteristics: Has chondrogenic potential.
CC   Senescence: Can undergo 15 PDL (ESI_BIO).
CC   Doubling time: ~50 hours (ESI_BIO).
CC   Discontinued: Millipore; SCC120; true.
CC   Discontinued: Millipore; SCR220; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
RX   Patent=US8685386;
RA   West M.D., Sternberg H., Chapman K.B.;
RT   "Methods and compositions for in vitro and in vivo chondrogenesis.";
RL   Patent number US8685386, 01-Apr-2014.
//
RX   PubMed=18462054; DOI=10.2217/17460751.3.3.287;
RA   West M.D., Sargent R.G., Long J., Brown C., Chu J.-S., Kessler S.,
RA   Derugin N., Sampathkumar J., Burrows C., Vaziri H., Williams R.,
RA   Chapman K.B., Larocca D., Loring J.F., Murai J.T.;
RT   "The ACTCellerate initiative: large-scale combinatorial cloning of
RT   novel human embryonic stem cell derivatives.";
RL   Regen. Med. 3:287-308(2008).
//
RX   PubMed=22519755; DOI=10.2217/rme.12.29;
RA   Sternberg H., Murai J.T., Erickson I.E., Funk W.D., Das S., Wang Q.,
RA   Snyder E.Y., Chapman K.B., Vangsness C.T. Jr., West M.D.;
RT   "A human embryonic stem cell-derived clonal progenitor cell line with
RT   chondrogenic potential and markers of craniofacial mesenchyme.";
RL   Regen. Med. 7:481-501(2012).
//